InvestorsHub Logo

Traderbx

01/23/18 9:53 AM

#50366 RE: Simple Steve #50361

lol thanks, complement it is indeed.

On a positive note:

There is is a Wall Street Journal article out today that mentions that 89% of biotech deals had $1 billion or more premium to the share price....

So if there ever happens to be a buyout, there is 89% possibility of a $20+ buyout price